Concentration of the alpha subunit of GTP-binding protein G0 in the cerebrospinal fluid of patients with neurological disorders
Murayama, T.; Matsuoka, Y.; Takahashi, A.; Asano, T.; Kato, K.
Rinsho Shinkeigaku 28(5): 525-531
1988
ISSN/ISBN: 0009-918X PMID: 3145824 Document Number: 311959
Document emailed within 1 workday
Related Documents
Whitaker, J.N.; Lisak, R.P.; Bashir, R.M.; Krance, R.; Lawrence, J.A.; Ch'ien, L.T.; O'Sullivan, P. 1978: Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders Transactions of the American Neurological Association 103: 212-215Maruyama, I.; Igata, A. 1979: Plasminogen concentration in the cerebrospinal fluid of patients with various neurological diseases Rinsho Shinkeigaku 19(8): 481-485
Shimatsu, A.; Kato, Y.; Tatsuoka, Y.; Yoshida, K.; Imura, H. 1985: Somatostatin and vasoactive intestinal polypeptide in the cerebrospinal fluid of patients with neurological disorders Rinsho Shinkeigaku 25(11): 1305-1310
Taj, A.; Jamil, N. 2016: Detection of meningococcal meningitis in cerebrospinal fluid of patients with neurological disorders in government hospitals of Karachi Jpma. Journal of the Pakistan Medical Association 66(11): 1418-1421
Beretti, F.; Pietrosemoli, P.; Bartoletti, A.Maria.; Rondini, I.; Portolani, M. 2006: Cerebrospinal fluid samples from patients with various neurological disorders have a transmissible cytotoxic activity with similar properties New Microbiologica 29(2): 143-146
Nakagawa, H.; Fujita, T.; Tsuruzono, K.; Kubo, S.; Yamada, M.; Miyawaki, Y.; Tokiyoshi, K.; Kanayama, T.; Hasegawa, H.; Koshino, K. 1994: Myelin basic protein in the cerebrospinal fluid of patients with neurological disease: especially with malignant brain tumors No Shinkei Geka. Neurological Surgery 22(2): 111-118
Fukuda, H.; Nakamura, S.; Hara, K.; Udaka, F.; Kameyama, M. 1989: Study on the concentration of 5-hydroxyindoleacetic acid (5-HIAA) in the lumbar cerebrospinal fluid (CSF) in neurological diseases Rinsho Shinkeigaku 29(9): 1192-1194
Pacifici, R.; Roman, J.; Kimble, R.; Civitelli, R.; Brownfield, C.M.; Bizzarri, C. 1994: Ligand binding to monocyte alpha 5 beta 1 integrin activates the alpha 2 beta 1 receptor via the alpha 5 subunit cytoplasmic domain and protein kinase C Journal of Immunology 153(5): 2222-2233
Marshall, T.; Williams, K.M. 2000: Protein determination in cerebrospinal fluid by protein dye-binding assay British Journal of Biomedical Science 57(4): 281-286
Giordano, C.; Clerc, M.; Doutriaux, C.; Piquemal, M. 1977: Cerebrospinal fluid gamma globulins in neurological disorders affecting black Africans La Nouvelle Presse Medicale 6(36): 3305-3308
McIntosh, J.C. 1977: Application of a dye-binding method to the determination of protein in urine and cerebrospinal fluid Clinical Chemistry 23(10): 1939-1940
Huang, C.M. 1988: Development and evaluation of an automated dye-binding assay for protein in cerebrospinal fluid Clinical Chemistry 34(5): 980-983
Matias-Guiu, J.; Ruibal, A.; Martinez-Vazquez, J.M.; Colomer, R.; Codina, A. 1986: Concentration of myelin basic protein in cerebrospinal fluid in prognosis of multiple sclerosis Clinical Chemistry 32(5): 915-916
Wiederkehr, F.; Vonderschmitt, D.J. 1985: 2-dimensional electrophoresis of cerebrospinal fluid in various neurological patients Schweizerische Medizinische Wochenschrift 115(11): 368-373
Tagami, T. 1970: Disc electrophoretic analysis of cerebrospinal fluid proteins in the disturbances of optic nerve. I. Comparison of cerebrospinal fluid at various sites in the cerebrospinal axis. With special reference to the cerebrospinal fluid in the chiasmatic cistern Nippon Ganka Gakkai Zasshi 74(9): 1129-1135
Suga, H.; Fujiyoshi, K.; Okamoto, K.; Nakamura, S.; Kameyama, M. 1984: Measurement of methionine-enkephalin-like immunoreactivity in the cerebrospinal fluid of various neurological patients Rinsho Shinkeigaku 24(9): 867-871
Levy, J.A.; Shimabukuro, J.; Hollander, H.; Mills, J.; Kaminsky, L. 1985: Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms Lancet 2(8455): 586-588
Fialová, L.; Bartos, A.; Soukupová, J.; Svarcová, J.; Ridzon, P.; Malbohan, I. 2009: Synergy of serum and cerebrospinal fluid antibodies against axonal cytoskeletal proteins in patients with different neurological diseases Folia Biologica 55(1): 23-26
Tournier-Lasserve, E.; Lyoncaen, O.; Roullet, E.; Bach, M.A. 1987: IL-2 receptor and HLA class Ii antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases Clinical and Experimental Immunology 67(3): 581-586
Valenti, M.; Sciarra, M.; Perotti, V.; Mignani, V.; Vergari, A.; Zanghi, F. 1990: Intraoperative changes in the concentration of xanthines in cerebrospinal fluid in patients with cerebral vasculopathy Minerva Anestesiologica 56(9): 671